Literature DB >> 346631

Lactulose syrup assessed in a double-blind study of elderly constipated patients.

J F Sanders.   

Abstract

The laxative effects of 50% lactulose syrup and 50% glucose syrup were compared in a 12-week, double-blind study of 47 elderly constipated patients living in a nursing home. The dosage was 30 ml daily taken at bedtime; it was reduced to 15 ml if the initial dosage produced two or more bowel movements daily. The number of bowel movements during treatment in comparison to pretreatment was significantly increased in the 42 patients (19 lactulose, 23 glucose) who completed at least 8 weeks of the study. Laculose was superior to glucose in the mean number of bowel movements per day (p less than 0.02) and in the percentage of days in which at least one bowel movement occurred (p less than 0.05). Reduction in the severity of each 5 symptoms (cramping, griping, flatulence, tenesmus, bloating) was greater with lactulose. For relief of all 5 symptoms, lactulose was significantly more effective than glucose (p less than 0.04). The striking reduction in the number of fecal impactions (only 6 in the lactulose patients vs 66 in the controls) was highly significant (p less than 0.015). The lactulose patients needed fewer enemas than did the controls. No abnormal values were observed in laboratory tests.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 346631     DOI: 10.1111/j.1532-5415.1978.tb01967.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  30 in total

1.  Lack of objective evidence of efficacy of laxatives in chronic constipation.

Authors:  Michael P Jones; Nicholas J Talley; Guy Nuyts; Dominique Dubois
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

2.  Opioid-induced bowel dysfunction.

Authors:  Howard Y Chang; Anthony J Lembo
Journal:  Curr Treat Options Gastroenterol       Date:  2008-02

Review 3.  Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.

Authors:  P Paré; Ronald Bridges; Malcolm C Champion; Subhas C Ganguli; James R Gray; E Jan Irvine; Victor Plourde; Pierre Poitras; Geoffrey K Turnbull; Paul Moayyedi; Nigel Flook; Stephen M Collins
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

Review 4.  Management of chronic constipation in the elderly.

Authors:  Paul F Gallagher; Denis O'Mahony; Eamonn M M Quigley
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

5.  Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation.

Authors:  A Attar; M Lémann; A Ferguson; M Halphen; M C Boutron; B Flourié; E Alix; M Salmeron; F Guillemot; S Chaussade; A M Ménard; J Moreau; G Naudin; M Barthet
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

6.  Laxatives.

Authors:  A G Lundell
Journal:  Can Fam Physician       Date:  1979-01       Impact factor: 3.275

Review 7.  Treatment of constipation in older people.

Authors:  Dov Gandell; Sharon E Straus; Maria Bundookwala; Vincent Tsui; Shabbir M H Alibhai
Journal:  CMAJ       Date:  2013-01-28       Impact factor: 8.262

Review 8.  Management of chronic constipation in patients with diabetes mellitus.

Authors:  V G M Prasad; Philip Abraham
Journal:  Indian J Gastroenterol       Date:  2016-12-17

9.  Tolerance and Long-Term Efficacy of Polyethylene Glycol 4000 (Forlax®) Compared to Lactulose in Elderly Patients with Chronic Constipation.

Authors:  P Chassagne; P Ducrotte; P Garnier; H Mathiex-Fortunet
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

10.  Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination.

Authors:  A P Passmore; K Wilson-Davies; C Stoker; M E Scott
Journal:  BMJ       Date:  1993-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.